Nothing Special   »   [go: up one dir, main page]

HUP0104963A2 - Bőrbetegségek kezelésére szolgáló készítmények - Google Patents

Bőrbetegségek kezelésére szolgáló készítmények

Info

Publication number
HUP0104963A2
HUP0104963A2 HU0104963A HUP0104963A HUP0104963A2 HU P0104963 A2 HUP0104963 A2 HU P0104963A2 HU 0104963 A HU0104963 A HU 0104963A HU P0104963 A HUP0104963 A HU P0104963A HU P0104963 A2 HUP0104963 A2 HU P0104963A2
Authority
HU
Hungary
Prior art keywords
treatment
skin diseases
compositions
hydrogen atom
group
Prior art date
Application number
HU0104963A
Other languages
English (en)
Inventor
Jan Adamus
Jerzy Gebicki
Anna Sysa-Jedrzejowska
Original Assignee
Technical University Of Lodz
Jan Adamus
Jerzy Gebicki
Anna Sysa-Jedrzejowska
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Technical University Of Lodz, Jan Adamus, Jerzy Gebicki, Anna Sysa-Jedrzejowska filed Critical Technical University Of Lodz
Publication of HUP0104963A2 publication Critical patent/HUP0104963A2/hu
Publication of HUP0104963A3 publication Critical patent/HUP0104963A3/hu
Publication of HU225475B1 publication Critical patent/HU225475B1/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dermatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A tal lm ny t rgya egy (I) ltal nos képletű vegyület alkalmaz sabőrbetegségek vagy -rendellenességek kezelésére szolg ló gyógyszer előllít s ra, ahol R jelentése -NR2R3 vagy -OR4 csoport; R1 jelentésemetilcsoport; R2 és R4 jelentése egym stól függetlenül hidrogénatomvagy 1-4 szénatomos alkilcsoport; R3 jelentése hidrogénatom, 1-4szénatomos alkilcsoport vagy -CH2OH; és X jelentése egy fiziológi sanalkalmas anion. Ó
HU0104963A 1999-01-07 2000-01-07 Nicotinamide- and nicotinic acid ester salts for use in therapy and cosmetology, pharmaceutical and cosmetic compositions containing them, and use of nicotinamide-, nicotinic acid- and... HU225475B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PL330768A PL190755B1 (pl) 1999-01-07 1999-01-07 Preparat do leczenia i profilaktyki chorób skóry
PCT/IB2000/000019 WO2000040559A1 (en) 1999-01-07 2000-01-07 Compositions for the treatment of skin diseases

Publications (3)

Publication Number Publication Date
HUP0104963A2 true HUP0104963A2 (hu) 2002-04-29
HUP0104963A3 HUP0104963A3 (en) 2002-11-28
HU225475B1 HU225475B1 (en) 2006-12-28

Family

ID=20073560

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0104963A HU225475B1 (en) 1999-01-07 2000-01-07 Nicotinamide- and nicotinic acid ester salts for use in therapy and cosmetology, pharmaceutical and cosmetic compositions containing them, and use of nicotinamide-, nicotinic acid- and...

Country Status (12)

Country Link
EP (1) EP1147086B9 (hu)
AT (1) ATE292117T1 (hu)
AU (1) AU1792700A (hu)
CZ (1) CZ299662B6 (hu)
DE (1) DE60019086T2 (hu)
ES (1) ES2238985T3 (hu)
HU (1) HU225475B1 (hu)
PL (2) PL190755B1 (hu)
RU (1) RU2199319C1 (hu)
SK (1) SK285869B6 (hu)
UA (1) UA73491C2 (hu)
WO (1) WO2000040559A1 (hu)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ303214B6 (cs) * 2001-03-21 2012-05-30 Torrent Pharmaceuticals Ltd Pyridiniová sloucenina, zpusob její výroby, její použití, farmaceutický prostredek ji obsahující, zpusob jeho výroby a jeho použití
PL364348A1 (en) 2004-01-12 2005-07-25 PHARMENA Sp.z o.o. Application of quaternary pyridine salts as vessel protection agent
DE102004013798A1 (de) * 2004-03-20 2005-10-06 Wella Aktiengesellschaft Verwendung von Mitteln zur kosmetischen Behandlung von Keratin enthaltenden Material
PL1919466T3 (pl) 2005-07-11 2012-05-31 Cortria Corp Formulacje do leczenia nieprawidłowości lipoproteinowych obejmujące statynę i pochodną metylonikotynoamidu
CA2629913A1 (en) * 2005-12-09 2007-06-14 Cerecon Ag Quaternary 3 -amido, n-methylpyridinium salts as anti -inflammatory agents
ES2418153T3 (es) * 2006-03-08 2013-08-12 Cortria Corporation Terapia de combinación con inhibidores no selectivos de COX para prevenir lesiones gástricas relacionadas con COX
WO2008062324A2 (en) * 2006-10-11 2008-05-29 Dermena Compositions comprising nicotinamide and wakame extract having skin anti-aging properties
EP2079471A2 (en) * 2006-10-18 2009-07-22 Dermena Food extracts containing n-methylnicotinamide for treatment of lipoprotein abnormalities and skin diseases and disorders
US20100240621A1 (en) * 2007-09-10 2010-09-23 Glenmark Pharmaceuticals Ltd. Topical pharmaceutical composition for the combination of fusidic acid and a corticosteroid
EP2211858B1 (en) 2007-10-12 2015-03-25 Politechnika Lodzka Use of quaternary pyridinium salts for inhibiting cancer metastases
TWI432188B (zh) * 2008-12-19 2014-04-01 Merz Pharma Gmbh & Co Kgaa 供治療發炎性皮膚疾病之１－胺基－烷基環己烷衍生物類
WO2018015862A1 (en) 2016-07-18 2018-01-25 Pharmena S.A. 1-methylnicotinamide salts for use in raising the blood levels of adiponectin
WO2021008824A1 (en) 2019-07-12 2021-01-21 Unilever Plc Bioenergetic combinations and methods of using same
WO2021205341A1 (en) 2020-04-07 2021-10-14 Pharmena S.A. 1-methylnicotinamide for the prevention/treatment of inflammatory airway diseases
PL444846A1 (pl) * 2023-05-10 2024-03-11 Politechnika Poznańska Sposób otrzymywania czwartorzędowych soli amoniowych z kationem 3-karbamoilo-1-alkilopirydyniowym i anionem salicylanowym

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3823076A (en) * 1972-05-23 1974-07-09 Du Pont Zinc electroplating additive
US4067975A (en) * 1975-08-04 1978-01-10 Yu Ruey J Treatment of psoriasis with 6-aminonicotinamide and thionicotinamide
US4505896A (en) * 1979-04-19 1985-03-19 Elorac, Ltd. Method of treating acne vulgaris and composition
US4578394A (en) * 1984-12-10 1986-03-25 Hoechst-Roussel Pharmaceuticals Incorporated Cholinergic function increasing 3-[N-(pyridyl) carbamoyl]-1,4-dihydropyridines
DE3603601C3 (de) * 1986-02-06 1999-12-23 Jutta Mai Verwendung eines Bockshornkleesamenextraktes
US4786647A (en) * 1986-06-30 1988-11-22 University Of Florida Method for eliciting anxiolysis
US5372911A (en) * 1991-06-13 1994-12-13 Dainippon Ink And Chemicals, Inc. Process of forming super high-contrast negative images and silver halide photographic material and developer being used therefor
AU7582398A (en) * 1997-05-19 1998-12-11 Rosemarie Scivoletto Composition for treating skin conditions

Also Published As

Publication number Publication date
ATE292117T1 (de) 2005-04-15
AU1792700A (en) 2000-07-24
ES2238985T3 (es) 2005-09-16
SK285869B6 (sk) 2007-10-04
WO2000040559A1 (en) 2000-07-13
UA73491C2 (uk) 2005-08-15
EP1147086A1 (en) 2001-10-24
SK9512001A3 (en) 2001-12-03
DE60019086D1 (de) 2005-05-04
RU2001121650A (ru) 2004-02-27
ES2238985T9 (es) 2011-03-24
HU225475B1 (en) 2006-12-28
HUP0104963A3 (en) 2002-11-28
CZ299662B6 (cs) 2008-10-08
RU2199319C1 (ru) 2003-02-27
EP1147086B1 (en) 2005-03-30
EP1147086B9 (en) 2010-09-22
PL190755B1 (pl) 2006-01-31
PL330768A1 (en) 2000-07-17
CZ20012450A3 (cs) 2002-10-16
PL396696A1 (pl) 2012-01-16
DE60019086T2 (de) 2006-02-02

Similar Documents

Publication Publication Date Title
HUP0101999A2 (hu) 4-Hidroxi-kinolin-3-karboxamid- és -hidrazid-származékok, ezeket tartalmazó gyógyászati készítmények, valamint e vegyületek alkalmazása
HUP0400710A2 (hu) Tioéter helyettesítővel helyettesített imidazokinolinszármazékok, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
HUP0104963A2 (hu) Bőrbetegségek kezelésére szolgáló készítmények
HUP0105437A2 (hu) Új malonsavszármazékok, előállításuk és alkalmazásuk, valamint e vegyületeket tartalmazó gyógyászati készítmények
MXPA04004837A (es) Inhibidores de 11-??-hidroxiesteroide deshidrogenasa de tipo 1.
NO20042596L (no) Inbibitorer av 11-beta-hydroksy steroid dehydrogenase type 1
HUP0301422A2 (hu) Ösztrogén hatású szereket tartalmazó gyógyászati készítmények
NO20021328L (no) Pyrazolopyrimidier som terapeutiske midler
HUP0203971A2 (hu) Imidazoimidazolok és -triazolok mint gyulladásellenes szerek és ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
HUP0204246A2 (hu) Új tiazolo[4,5-d]pirimidin-származékok, eljárás az előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
HUP0103887A2 (hu) N-aralkilaminotetralinok neuropeptid Y Y5 receptor ligandumként és ilyen vegyületeket hatóanyagként tartalmazó gyógyszerkészítmények
HUP0402225A2 (hu) Makrolid-vegyületek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
HUP0401638A2 (hu) Daganatellenes hatású tiofén- és tiazolszulfonamid származékok, valamint ezeket tartalmazó gyógyászati készítmények
HUP0102602A2 (hu) Diacil-hidrazinszármazékok, előállításuk és alkalmazásuk, valamint e vegyületeket tartalmazó gyógyászati készítmények
AU3850600A (en) Dalda analogs and their use
HUP9700005A2 (hu) 2-Ureido-benzamid-származékok és ilyeneket hatóanyagként tartalmazó gyógyszerkészítmények
HUP0003757A2 (hu) Levosimendant tartalmazó orális gyógyászati készítmények
HUP0203716A2 (hu) Tumorellenes hatású szubsztituált (N-benzil-indol-3-il)-glioxilsav-származékok, ezeket tartalmazó gyógyszerkészítmények
RS44204A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
HUP0003577A2 (hu) Tetrahidro-gamma-karbolinok, eljárás előállításukra, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények
HUP0002963A2 (hu) Pirazolo-[4,3-d] pirimidinon-származékok alkalmazása a szem betegségeinek kezelésére szolgáló gyógyszerkészítmények előállítására
HUP9902683A2 (hu) 3,4-Difenil-krománok alkalmazása menopauzális szimptómák kezelésére vagy megelőző kezelésére alkalmas gyógyszerkészítmények előállítására
HUP0202803A2 (en) Titanium derived compounds, preparation and use thereof
DE69819539D1 (de) Antithrombotische mittel
HUP0300295A2 (hu) Helyettesített benzamidszármazékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk